Jenscare Scientific Co Ltd
HKEX:9877
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
CN |
Jenscare Scientific Co Ltd
Total Equity
Jenscare Scientific Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jenscare Scientific Co Ltd
HKEX:9877
|
Total Equity
¥789.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Equity
¥3.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Equity
¥13.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Equity
¥38.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Total Equity
¥22.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
61%
|
CAGR 10-Years
41%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Equity
¥19.9B
|
CAGR 3-Years
58%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Jenscare Scientific Co Ltd
Glance View
Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. The company is headquartered in Ningbo, Zhejiang. The company went IPO on 2022-10-10. The firm develops interventional products for the treatment of structural heart disease. The firm's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The firm also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. The firm mainly conducts its businesses in the domestic market.
See Also
What is Jenscare Scientific Co Ltd's Total Equity?
Total Equity
789.4m
CNY
Based on the financial report for Dec 31, 2025, Jenscare Scientific Co Ltd's Total Equity amounts to 789.4m CNY.
What is Jenscare Scientific Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
17%
Over the last year, the Total Equity growth was -15%. The average annual Total Equity growth rates for Jenscare Scientific Co Ltd have been -17% over the past three years , 17% over the past five years .
